Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...
That same month, the FTC published a report describing PBMs as powerful middlemen who “may be profiting by inflating drug ...
Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action "This action continues a troubling pattern ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.
The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback